Paraaortal Lymphadenectomy in the Treatment of Ovarian Cancer

Czech version

Authors: Freitag; Živný; Kužel; Adamec; Jančárková
Authors‘ workplace: Gynekologcko-porodnická klinika 1. LF UK a VFN, Praha, přednosta prof. MUDr. J. Živný, DrSc., Klinika transplantační chirurgie IKEM, Praha, přednosta doc. MUDr. M. Ryska, Csc.
Published in: Ceska Gynekol 2001; (1): 29-32
Category:

Overview

Structured AbstractObjective:
Analysis of nodal pelvic and paraaortal findings in patients operated on for ovariancancer.Design: Retrospective study.Setting: Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University,Prague.Methods: Analysis of a series of 30 patients - assesment of median age, staging, grading, histologi-cal findings, percentage of pelvic and paraaortic nodal involvement, median number of lympho-nodes.Results: Median age of the series was 54 years, 15 patients had an early ovarian cancer and 15patients advanced ovarian cancer. Paraaortal lymphadenectomy revealed metastatic involvementof lymphonodes in 8/30 cases (26,7%) and pelvic lymphadenectomy in 4/18 cases (22,7%). Involve-ment of any lymphonodes had 9 patients (30%). In a group of patients with early ovarian cancerno case had a nodal involvement, in a group of advanced ovarian cancer 9/15 (60%) patients werepositive. Median numbers of removed pelvic and paraaortal lymphonodes were 8,3 resp. 5,4 nodes.Conclusion: Pelvic and paraaortal lymphadenectomy in ovarian cancer have especially a stagingimportance with adequate therapeutic consequencies. Currently a sampling extent of operation ispreferred to systematic lymphadenectomy. It is recommended to concentrate operations to onco-gynecological centers.

Key words:
ovarian cancer, paraaortal lymphadenectomy

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.